RIGVIR

Oncolytic virotherapy is an official, innovative, and effective cancer treatment using a special virus that is capable of finding and destroying cells of a malignant tumor in the human body. The medication is injected into a muscle. Rigvir is an immunomodulator with an anti-tumor effect for the treatment of melanoma, local treatment of skin and subcutaneous metastases of melanoma, and prevention of relapse and metastasis.

Additional Resources:

• https://pubmed.ncbi.nlm.nih.gov/33053757
• https://pubmed.ncbi.nlm.nih.gov/33738818
• https://pubmed.ncbi.nlm.nih.gov/33575873
• https://pubmed.ncbi.nlm.nih.gov/34901031
• https://pubmed.ncbi.nlm.nih.gov/34631474
• https://pubmed.ncbi.nlm.nih.gov/34563270
• https://pubmed.ncbi.nlm.nih.gov/33524945
• https://pubmed.ncbi.nlm.nih.gov/33633364
• https://pubmed.ncbi.nlm.nih.gov/34735984
• https://pubmed.ncbi.nlm.nih.gov/33053757
• https://pubmed.ncbi.nlm.nih.gov/33086754
• https://pubmed.ncbi.nlm.nih.gov/33213031